SS Innovations International Inc. (NASDAQ: SSII) has reported record second-quarter revenue of $13.9 million, a 39.4% increase year over year, driven by continued adoption of its SSi Mantra surgical robotic system. The company’s first-half revenue reached $25.0 million, up 65.6% from the same period in 2025, underscoring the accelerating commercial traction of its robotic surgery platform.
The revenue growth was accompanied by a 30.4% rise in SSi Mantra installations during the quarter, bringing the total installed base to 224 systems across 12 countries. Cumulative surgeries performed using the platform reached 12,272, reflecting growing clinical utilization. The company’s telesurgery achievements are also extending the clinical profile of the system, although installations remain the primary commercial growth driver.
The company’s financial performance highlights the increasing demand for robotic-assisted surgery in global markets. Gross profit for the second quarter increased 20.0% to $7.1 million, while gross margin declined to 50.9% from 59.1% in the year-earlier quarter. For the first half, gross profit rose 77.5% to $12.4 million, with an improved gross margin compared to the prior year period. These figures indicate that while the company is scaling its operations, it continues to invest in growth initiatives.
Looking ahead, regulatory milestones in the United States and Europe could serve as important catalysts for SS Innovations. The company is targeting FDA clearance for SSi Mantra by the first quarter of 2027 and EU CE marking by the end of 2026. Achieving these approvals would open access to two of the largest robotic surgery markets, potentially accelerating adoption and revenue growth.
The company’s telesurgery capabilities, which allow surgeons to operate remotely, are expanding the clinical applications of SSi Mantra. This technology could enhance access to specialized surgical care in underserved regions, differentiating the platform from competitors. However, the near-term growth strategy remains centered on increasing system installations, which directly contribute to recurring procedure volumes and future service revenue.
As SS Innovations continues to expand its global footprint, the combination of rising installations, a growing surgical volume, and upcoming regulatory milestones positions the company for sustained momentum. The reported financial results and operational progress provide a foundation for future expansion, though investors will be watching for continued execution and margin trends.
For more information on SS Innovations, visit the company’s newsroom at https://nnw.fm/SSII.
